Abstract:The aggregation of soluble amyloid‐beta (Aβ) peptide into oligomers/fibrils is one of the key pathological features in Alzheimer's disease (AD). The Aβ aggregates are considered to play a pivotal role in the pathogenesis of AD. Therefore, inhibiting Aβ aggregation and destabilizing preformed Aβ fibrils would be an attractive therapeutic target for prevention and treatment of AD. S14G‐humanin (HNG), a synthetic derivative of Humanin (HN), has been shown to be a strong neuroprotective agent against various AD‐related insults. Recent studies have shown that HNG can significantly improve cognitive deficits and reduce insoluble Aβ levels as well as amyloid plaque burden without affecting amyloid precursor protein processing and Aβ production in transgenic AD models. However, the potential mechanisms by which HNG reduces Aβ‐related pathology in vivo remain obscure. In the present study, we found that HNG could significantly inhibit monomeric Aβ1–42 aggregation into fibrils and destabilize preformed Aβ1–42 fibrils in a concentration‐dependent manner by Thioflavin T fluorescence assay. In transmission electron microscope study, we observed that HNG was effective in inhibiting Aβ1–42 fibril formation and disrupting preformed Aβ1–42 fibrils, exhibiting various types of amorphous aggregates without identifiable Aβ fibrils. Furthermore, HNG‐treated monomeric or fibrillar Aβ1–42 was found to significantly reduce Aβ1–42‐mediated cytotoxic effects on PC12 cells in a dose‐dependent manner by MTT assay. Collectively, our results demonstrate for the first time that HNG not only inhibits Aβ1–42 fibril formation but also disaggregates preformed Aβ1–42 fibrils, which provides the novel evidence that HNG may have anti‐Aβ aggregation and fibrillogenesis, and fibril‐destabilizing properties. Together with previous studies, we concluded that HNG may have promising therapeutic potential as a multitarget agent for the prevention and/or treatment of AD. Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Effect of humanin and [Gly14]-humanin on expression of hippocampal glial fibrillary acidic protein in mice with Alzheimer disease

Protective Effect of S14G-humanin Against Beta-Amyloid Induced LTP Inhibition in Mouse Hippocampal Slices.

Ganoderma Lucidum Triterpenoids (glts) Reduce Neuronal Apoptosis Via Inhibition of ROCK Signal Pathway in APP/PS1 Transgenic Alzheimer's Disease Mice

RETRACTED: S14G-Humanin Ameliorates Aβ25-35-induced Behavioral Deficits by Reducing Neuroinflammatory Responses and Apoptosis in Mice

S14G-Humanin Improves Cognitive Deficits and Reduces Amyloid Pathology in the Middle-Aged APPswe/PS1dE9 Mice

Protective effects of [Gly14]-Humanin on β-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction

Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrogenesis of Aβ1–40

Retracted: S14G‐humanin Inhibits Aβ1–42 Fibril Formation, Disaggregates Preformed Fibrils, and Protects Against Aβ‐induced Cytotoxicity in Vitro

[Gly14]-Humanin Reduces Histopathology and Improves Functional Outcome after Traumatic Brain Injury in Mice.

(1)H-MRS Evaluation of Therapeutic Effect of Neural Stem Cell Transplantation on Alzheimer's Disease in AβPP/PS1 Double Transgenic Mice.

[Gly14]-Humanin Offers Neuroprotection Through Glycogen Synthase Kinase-3Β Inhibition in a Mouse Model of Intracerebral Hemorrhage

Geranylgeranylacetone induce the expression of heat shock protein 70 in hippocampus of Alzheimer's model rats and it's neuroprotective effect on the rats

S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.

Effect of Neural Stem Cells Transplantation on Protein Expressions of Doublecortin and Nestin in Hippocampal Regions in App/ps1 Mice

Neuroprotective Effect of [Gly14]-Humanin in Rats with Intracerebral Hemorrhage

Protective Effect of Recombinant Human Somatotropin on Amyloid Beta-Peptide Induced Learning and Memory Deficits in Mice.

The Protective Effects of the β-aescinate on Cerebral Inflammatory Damage of Alzheimer Disease Model in Rats

Intranasal Administration of TAT-haFGF14–154 Attenuates Disease Progression in a Mouse Model of Alzheimer’s Disease

Geranylgeranylacetone (GGA) increases HSP70 expression, reduces apoptosis and improves the learning and memory ability in rat model of Alzheimer's disease

Effect of Butylphthalide on Expression of NeuN and IL-1 in Model Rats with Alzheimer disease.

The Neuroprotective Effect of Neural Cell Adhesion Molecule L1 in the Hippocampus of Aged Alzheimer's Disease Model Mice